Author:
Pethe Kevin,Sequeira Patricia C.,Agarwalla Sanjay,Rhee Kyu,Kuhen Kelli,Phong Wai Yee,Patel Viral,Beer David,Walker John R.,Duraiswamy Jeyaraj,Jiricek Jan,Keller Thomas H.,Chatterjee Arnab,Tan Mai Ping,Ujjini Manjunatha,Rao Srinivasa P.S.,Camacho Luis,Bifani Pablo,Mak Puiying A.,Ma Ida,Barnes S. Whitney,Chen Zhong,Plouffe David,Thayalan Pamela,Ng Seow Hwee,Au Melvin,Lee Boon Heng,Tan Bee Huat,Ravindran Sindhu,Nanjundappa Mahesh,Lin Xiuhua,Goh Anne,Lakshminarayana Suresh B.,Shoen Carolyn,Cynamon Michael,Kreiswirth Barry,Dartois Veronique,Peters Eric C.,Glynne Richard,Brenner Sydney,Dick Thomas
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference47 articles.
1. East African-British Medical Research Councils. Controlled clinical trial of short course 6 month regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet 1, 1079–1085 (1972).
2. Results at 5 years of a controlled comparison of a 6-month and a standard 18-month regimen of chemotherapy for pulmonary tuberculosis. Am. Rev. Respir. Dis. 116, 3–8 (1977).
3. Somner, A. R. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic Association (third report). Lancet 1, 1182–1183 (1980).
4. Zignol, M. et al. Global incidence of multidrug-resistant tuberculosis. J. Infect. Dis. 194, 479–485 (2006).
5. Young, D. B., Perkins, M. D., Duncan, K. & Barry, C. E. III Confronting the scientific obstacles to global control of tuberculosis. J. Clin. Invest. 118, 1255–1265 (2008).